Krónikus limfoid leukémia (CLL): vizsgálatok itt: Belarusz
1 of 2 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peoplePhase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.
- Where
- Vitebsk
- Életkor
- 18 év and over
- People
- 24
- Run by
- Vitebsk Regional Clinical Cancer Centre
See details and how to joinNCT06762431